Psychedelic agonists of serotonin receptors induce neural plasticity and synaptogenesis, but their potential to enhance learning remains uncharted. Here we show that a single dose of d-LSD, a potent serotonergic agonist, increased novel object preference in young and adult rats several days after treatment. d-LSD alone did not increase preference in old animals, but could rescue it to young levels when followed by a 6-day exposure to enriched environment (EE).
Introduction
Normal aging is associated with a decline in cognitive abilities, such as learning capacity, processing speed, working memory, and executive functions (1, 2) . Cognitive aging is thought to reflect decreased synaptogenesis in elderly individuals (3) . In the 1960s and 1970s, psychedelic substances that are agonists of serotonin receptors were extensively used in psychotherapy because of their potential to cause long-lasting psychological changes (4) (5) (6) (7) . Decades of prohibitive regulation prevented research on the cognitive benefits of serotonergic agonists, but in the past years psychedelic research is undergoing a major renaissance (8) (9) (10) (11) , particularly in psychiatric conditions. Agonists of serotonin receptors have been shown to have foremost utility for the treatment of depression (12, 13) and terminal anxiety (14) (15) (16) . The use of serotonergic psychedelics is associated with decreased psychological suffering and lower suicide rates (17) . These substances have also been shown to induce neural plasticity and synaptogenesis both in vitro and in vivo (18) (19) (20) , and are therefore likely to enhance learning capacity. Indeed, psychedelics have been shown to enhance memory consolidation when administered after fear learning or novel object exploration (21, 22) . In the former, a single dose immediately after learning enhanced memory consolidation in adult mice, while treatment immediately before learning facilitated the extinction of fear memory (21) . In the latter, chronic treatment of adult rats with d-LSD for 11 days improved learning in animals deprived of olfaction by bulbectomy, but no effects were observed in sham controls (22) . The lesion increases hippocampal 5-HT2A levels, and d-LSD down-regulated these to normal levels, with no effects in sham animals. The main interpretation proposed for these findings was that the post-learning activation of 5-HT2A receptors improves memory consolidation, and promotes positive mood changes. Neither study investigated the effects of d-LSD treatment several days before the learning task. Thus, we hypothesized that d-LSD treatment before a given learning task would increase synaptogenesis, creating a rich synaptic landscape that should favor the encoding of new memories.
Results & Discussion
To test this hypothesis we first explored how a pre-treatment with d-LSD at various concentrations and time intervals ( Figure 1A) would affect subsequent novel object preference (Figure 1B) in young, adult and old rats (Suppl . Table   S1 ). The reference dose chosen for treatment (0.13 mg/kg) was determined by the current literature as required for the activation of 5-HT2A receptors, as indicated by the occurrence of wet dog shakes (23) . For comparison, we also tested half and triple doses (0.065 mg/kg and 0.39 mg/kg, respectively). The choice of serotonergic agonist -lysergic acid diethylamide (d-LSD) -was determined by its extremely low toxicity and effective dose, which makes d-LSD stand out among all other similar molecules (24) .
Using the reference dose, we found that d-LSD treatment significantly increased novel object preference in adults (p = 0.008), from 44.16 ± 7.49% in saline controls to 62.65 ± 5.07% in d-LSD treated animals (median ± sd). In young animals the effect was also detected (p=0.05), with an increase from 58.57 ± 9.06% in saline controls to 67.95 %± 13.13% in d-LSD treated animals (median ± sd; Figure 1C ; Suppl. Tables S2,S3 ). When different d-LSD doses were compared in adult animals, a maximum of novel object preference was found for the intermediate dose of 0.13 mg/kg ( Figure 1D) . Daily doses of 0.13 mg/kg for 3 consecutive days were not as effective as the single dose; nor did a single application of a triple dose (0.39 mg/kg) produce more gain with a longer interval (Suppl. Figure S1A) . Importantly, old animals did not display differences in novel object exploration after a single d-LSD dose ( Figure 1C) .
Moreover, the efficiency of d-LSD in increasing explorative behavior correlated negatively with both weight and age (Suppl. Figures S1B,C; Suppl. Table S4 ).
Since exposure to an enriched environment (EE) enhances learning & memory in aging rodents (25, 26) , we hypothesized that d-LSD treatment followed by several days of EE exposure could promote a cognitive rescue of the old animals. To test this idea we treated old rats with 0.13 mg/kg of d-LSD for 1 or 3 days, followed by 3h of EE exposure for 6 days (Figure 1E ). Both combinations of d-LSD treatment with EE led to a significant increase from baseline levels (i.e. saline controls without EE) ( Figure 1F) . Treatment with d-LSD for 1 day followed by EE also led to significantly more novel object exploration than saline followed by EE; a non-significant trend in the same direction was detected for 3 days of d-LSD treatment followed by EE ( Figure   1F ). The different age groups did not show significant differences in the total time exploring objects (Suppl. Figure S1D) . Overall the data indicate that a single dose of d-LSD increases cognition whenever plasticity is present, but is insufficient to rescue cognitive losses caused by ageing. However, it also indicates that once brain plasticity is by other means stimulated in old rats, d-LSD can boost the effect. To investigate the molecular mechanisms underlying the cognitive benefits of d-LSD treatment, we tested whether d-LSD is able to alter expression of genes associated with brain plasticity in vitro. While this has been demonstrated in rats both in vitro and in vivo (20) , similar effects remain to be shown in human neurons. One of the greatest caveats for studying cellular and molecular effects of any psychedelic compound is the relative difficulty of obtaining brain cells from human donors. To overcome this limitation, we used human induced pluripotent stem cells (iPSCs) to generate brain organoids that recapitulate some aspects of patterning, organization, and connectivity observed in the embryonic human brain (27) .
Brain organoids generated from human iPSCs were grown in agitation and used for the experiments at day 45, when they already express most of the transcription factors and a protein profile consistent with differentiated brain regions (28) . Organoids were treated for 24 h with 10 nM d-LSD and processed by mass spectrometry-based proteomics in order to systematically approach the lysergic effects in human neural cells. Liquid chromatography-mass spectrometry (LC-MS) based proteomics of control and d-LSD identified 3,448 proteins in 3 biological replicates (Suppl . Table S5 ). We used a String network to analyze a total of 234 proteins with expression significantly modified by d-LSD treatment (p<0.05). This tool allows searching for experimental and correlational data connecting proteins in an interaction network (Figure 2A ).
From this network we identified enriched categories of cell components, such as the term 'neuron part' (red circles, 14% of hits, q = 0.01), and the term 'synapse' (blue circles, 9 % of hits, q = 0.02).
In addition, gene ontology (GO) enrichment analysis, using the DAVID bioinformatics tool shows other 'cell compartment' terms enriched ( Figure 2B) .
See highlighted the enrichment for the term 'presynaptic active zone' (p= 0,005; . Table S4 ), suggesting that the increase in synaptic proteins was not due to an increase in the number of neurons.
SYP is a major integral membrane protein that binds to synaptobrevin and is ubiquitously expressed in synapses throughout the mammalian brain (29) .
Synapse formation is one of the main neuroplastic changes and correlates with cognition. Interestingly, SYP stands out as a highly upregulated protein within the categories of the GO analysis. In order to confirm whether d-LSD was affecting synaptic proteins, and SYP in particular, we performed an immunofluorescence staining for SYP in brain organoids kept in the presence or absence of d-LSD for 4 days. SYP was mainly expressed in the part of the organoid that resembles the structural organization of the cortical plate (27), the preferential location of the neurons (Figure 2C-F) . d-LSD induced a more than 2fold increase in the levels of SYP in the cortical plate-like region of the human brain organoids ( Figure 2H) . These data suggest that d-LSD stimulates young neurons to increase the expression of SYP, thus becoming more prone to form additional new synapses. To understand the association of SYP up-regulation with cognitive enhancement, we manipulated the proprieties of synaptic connectivity in a composite model of the hippocampus (30) and the prefrontal cortex (31, 32) used to emulate the novel object preference task ( Figure 3A) . Altering the balance of pattern separation and completion in the hippocampus (Figure 3B) , the internal connectivity of prefrontal cortex (Figure 3C) , and the strength of coupling between these areas (Figure 3D) impacted the estimated preference for novelty independently and allowed for an interpretation of the differences in the behavioral results of adult and old rats (Figure 3E) . The use of long-range connectivity as a proxy for age (33, 34) provided an explanation for age differences in baseline performance and cognitive enhancement ( Figure 3D ):
Young rats start at a high baseline level, but still with room for improvement; adult and old rats start at neutral performance level, but with the connectivity levels for adult rats sitting next to an inflection and for old rats at a plateau. A small increase in connectivity within the local circuits of the prefrontal cortex further impedes the cognitive enhancement in old rats (Figure 3C The results indicate that d-LSD can substantially increase synaptic plasticity in human neurons in vitro, and novelty preference in behaving rats.
Altogether, they support the use of d-LSD to enhance learning, chart the molecular pathways underlying this effect, and show for the first time that d-LSD modulates synaptic proteins in human neurons. Of note, the computational modeling of synaptic connectivity in mnemonic and executive brain regions demonstrated that superior pattern separation in the EE is sufficient to explain its synergy with d-LSD in the cognitive rescue of old animals.
The results also suggest that the potent anti-depressant effects of serotonergic psychedelics (12) (13) (14) (15) (16) (36) (37) (38) may stem in part from a boost in synaptogenesis that increases learning capacity and drives curiosity outwards.
The same mechanisms make this class of drugs one of the greatest promises among cognitive enhancers (39, 40) , side by side with Δ-9-tetrahydrocannabinol, which also involves SYP (41), and likely overlap with the mechanisms of sleepinduced synaptogenesis (42) . Future studies must determine how to optimize the action of serotonergic psychedelics so as to rescue the learning deficits brought by natural or pathological aging (1) (2) (3) . 
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Material & Methods
Research permits: ANVISA AEP no. 003/2018, ANVISA AEP no. 019/2019 and CEUA UFRN # 011.2015.
Drug: The study used high-purity d-LSD dissolved in ultrapure water (18.2 MΩ.cm). The solution was manipulated at room temperature and light exposure was avoided. The analytical characterization is described on Suppl.
Information.
Animals: Wistar rats (n=96) on different age groups comprising young (2 months), adult (9 months) and old (12-18 months) animals received 1 or 3 daily intra-peritoneal injections of saline or d-LSD doses of 0.065mg/kg, 0.13mg/kg and 0.39mg/kg (Suppl . Table S1 ). Before the injection the animals were housed with other individuals, after the application of saline or d-LSD the animals were housed individually. For ten hours following the injection, animals were videorecorded and stayed alone during the acute effect of the drug/saline. After that, each rat was housed in cages with 4 more individuals.
Novel object preference task: The square arena where the novel object preference task took place (44 x 44 x 41 cm) had two 3D printed bases fixed on the floor 11 cm apart, for the firm placement of the objects, which were assembled with the same number and types of LEGO™ pieces. On the 3 days preceding the task, animals were habituated for 10 min to the task arena. Two Enriched Environment (EE): Old animals were placed in an EE for 3h every day, during 6 days. On the last 3 days, they were also habituated for 10 min to the arena used in the novel object preference task. The EE was made of card boxes with 8 different rooms, in which it was possible to find PVC tubes, toilet paper cardboard tubes, wood-made objects and hidden fruit loops to stimulate exploratory behavior. Animals explored the environment freely in groups of 3-5 animals. The effect of d-LSD followed by EE was analyzed using one-way ANOVA, followed by Tukey HSD. The statistical analyses were performed using open source programming language R (Version 3.6.0). The Mann-Whitney U test was used to compare the performance of old animals exposed to EE to that of old animals treated with saline and unexposed to EE.
Brain organoid preparation: GM23279A, an induced pluripotent cell (iPSC) line from the NIGMS Human Genetic Cell Repository obtained and certified by the Coriell cell repository was used in this study. iPSCs were maintained with mTeSR1 medium and upon confluence passaged manually or with EDTA. iPSC cultures with no differentiated cells were used to prepare brain organoids following a previously described protocol (28) . Shortly, iPSCs were detached using Accutase for 5 min at 37°C, detached cells were then added to phosphate-buffered saline (PBS; LGC Biotechnology, USA) containing 10µM ROCK inhibitor (ROCKi, Y27632; Merck Millipore, USA) to a final concentration of 10 μM and dissociated to single cells. Cells were centrifuged at 300 rpm for 5 min and pellet was resuspended in hESC medium (20% knockout serum replacement; Life Technologies), 3% ESC-quality fetal bovine serum (Thermo Fisher Scientific, USA), 1% GlutaMAX (Life Technologies, Canada), 1% minimum essential medium non-essential amino acids (MEM-NEAAs; Life Technologies), 0.7% 2-mercapto-ethanol, and 1% penicillin-streptomycin (P/S; Life Technologies). 9,000 cells were plated per well of an ultra-low attachment 96 well plate in hESC medium containing 50 µM ROCKi and 4 ng/ml b-FGF. After plating the plate was spinned at 300 rpm for 1 min. On days 3 and 5 medium was changed. At this stage, embryoid bodies (EBs) were formed and grew larger. On day 7 EBs were transferred to ultra-low attachment 24 well plates and media was changed to neuroinduction media [1% N2 supplement (Gibco), 1% GlutaMAX (Life Technologies), 1% MEM-NEAAs, 1% P/S, and 1 μg/ml heparin in DMEM/F12 (Life Technologies)]. The neuroinduction media was changed at day 9 and at day 11 the tissue was submitted to 1 h Matrigel bath. After that, media was changed to differentiation media minus vitamin A (50% neurobasal medium, 0.5% N2, 1% B27 supplement without vitamin A, 1:100 2-mercapto-ethanol, 0.5% MEM-NEAA, 1% GlutaMAX, and 1:100 P/S in DMEM/F12) and on day 13 the media was changed. On day 15 organoids were transferred to agitation in 6 well plates at 90 rpm, media was changed to differentiation media plus vitamin A (50% neurobasal medium, 0.5% N2, 1% B27 supplement with vitamin A, Data analysis: Further statistical analyses of the list with identified proteins and normalized intensity data was performed using the Perseus software (45, 46) . Fold change of the intensities assigned to each protein was calculated within each experimental batch. Fold change values were normalized using the vsn package in RStudio (47, 48) . Statistical analyses were performed with one sample t-test (p<0.05) against 0 value (no change). Significant hits were subjected to gene enrichment using String (49) and DAVID (50) online bioinformatics tools.
Immunostaining: Brain organoids were treated with 10 nM d-LSD for 4 days, and fixed overnight in 4% paraformaldehyde (Sigma-Aldrich, USA). Organoids were then incubated in 30% sucrose for dehydration, frozen in optimal cutting temperature compound on dry ice, and stored at -80°C. The organoids were with each other through shared recurrent inhibitory connections mediated by the interneurons. All connections within the decision circuit could also be altered to allow the manipulation of decision dynamics. In the model, a decision occurred when the difference in mean activity between the exploratory and nonexploratory pool was above 12 Hz (32). To estimate the time exploring novelty, we computed the proportion of novel trials in which a decision was made towards exploration compared to all cases, i.e., novel and familiar pattern simulations. We simulated 100 blocks of 100 trials per condition (connectivity variation and novel/familiar pattern presented).
